In addition to several other transgenic overexpression models, an Atxn2-CAG42 knock-in (KIN) mouse model was generated, which showed very mild neurological disease signs towards the end of normal mouse lifespan without obvious metabolic alterations [22]. This evidence concerns the gene ATXN2 and nervous system disorder.